The proteome of central and peripheral retina with progression of age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2280-2290

  Ethen, Cheryl M ^a   Reilly, Cavan ^a   Feng, Xiao ^a   Olsen, Timothy W ^a   Ferrington, Deborah A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 380 Lions Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; PROTEOME;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CASE REPORT; CAUSAL ATTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DONOR; FEMALE; HUMAN; HUMAN TISSUE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROTUBULE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM; RETINA; RETINA MACULA AGE RELATED DEGENERATION; SOMATOSENSORY CORTEX; STRESS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; FISCHER 344 RAT; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; RETINA MACULA DEGENERATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROTEOME; RATS; RATS, INBRED F344; RETINA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33745650321     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1395     Document Type: Article

References (49)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
2. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24:335-610.
3. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541-560.
4. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol. 1999;117:1329-1345.
5. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
6. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44(suppl 1):S10-S32.
7. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006;82:99-110.
8. Martin G, Schlunck G, Hansen LL, Agostini HT. Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol. 2004;242:321-326.
9. Eckmiller MS. Defective cone photoreceptor cytoskeleton, alignment, feedback, and energetics can lead to energy depletion in macular degeneration. Prog Retin Eye Res. 2004;23:495-522.
10. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598-614.
11. Owsley C, Jackson GR, Cideciyan AV, et al. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:267-273.
12. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
13. Jackson GR, Owsley C, Curcio CA. Photoreceptor degeneration and dysfunction in aging and age-related maculopathy. Ageing Res Rev. 2002;1:381-396.
14. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci. 1993;34:3278-3296.
15. Gorin MB, Jackson KE, Ferrell RE, et al. A peripherin/retinal degeneration slow mutation (Pro-210-Arg) associated with macular and peripheral retinal degeneration. Ophthalmology. 1995;102:246-255.
16. Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol. 2005;123:935-938.
17. Khurana RN, Fujii GY, Walsh AC, Humayun MS, de Juan E Jr, Sadda SR. Rapid recurrence of geographic atrophy after full macular translocation for nonexudative age-related macular degeneration. Ophthalmology. 2005;112:1586-1591.
18. Simon P, Glacet-Bernard A, Coscas G, Soubrane G. Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia [in French]. J Fr Ophtalmol. 2002;25:694-700.
19. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257-293.
20. Olsen TW, Feng X. The Minnesota Grading System of eye bank eyes for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:4484-4490.
21. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132:668-681.
22. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128-1134.
23. Ethen CM, Feng X, Olsen TW, Ferrington DA. Declines in arrestin and rhodopsin in the macula with progression of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:769-775.
24. Kapphahn RJ, Ethen CM, Peters EA, Higgins L, Ferrington DA. Modified alpha A crystallin in the retina: altered expression and truncation with aging. Biochemistry. 2003;42:15310-15125.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
26. Ferrington DA, Krainev AG, Bigelow DJ. Altered turnover of calcium regulatory proteins of the sarcoplasmic reticulum in aged skeletal muscle. J Biol Chem. 1998;273:5885-5891.
27. Crabb JW, Miyagi M, Gu X. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682-14687.
28. Merril CR, Washart KM. Protein detection methods. In: Hames BD, ed. Gel Electrophoresis of Proteins. New York: Oxford University Press, Inc.; 1998:57-61.
29. Nordgaard CL, Berg KM, Kapphahn RJ, et al. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:815-822.
30. Means GE, Feeney RE, Martin BL. Chemical and post-translational modification of proteins. In: Chambers JA, Rickwood D, eds. Biochemistry. Oxford, UK: BIOS Scientific Publishers Limited, Oxford, 1993:215-245.
31. Lewis H, Straatsma BR, Foos RY, Lightfoot DO. Reticular degeneration of the pigment epithelium. Ophthalmology. 1985;92:1485-1495.
32. Postel EA, Agarwal A, Schmidt S, et al. Comparing age-related macular degeneration phenotype in probands from singleton and multiplex families. Am J Ophthalmol. 2005;139:820-825.
33. Traboulsi EI. The challenges and surprises of studying the genetics of age-related macular degeneration. Am J Ophthalmol. 2005;139:908-911.
34. Lopez-Fanarraga M, Avila J, Guasch A, Coll M, Zabala JC. Review: postchaperonin tubulin folding cofactors and their role in microtubule dynamics. J Struct Biol. 2001;135:219-229.
35. Cowan NJ, Lewis SA. Type II chaperonins, prefoldin, and the tubulin-specific chaperones. Adv Protein Chem. 2001;59:73-104.
36. Vainberg IE, Lewis SA, Rommelaere H, et al. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell. 1998;93:863-873.
37. Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration and aging. J Neurosci Res. 2002;70:264-273.
38. Nakazawa T, Nakano I, Furuyama T, Morii H, Tamai M, Mori N. The SCG10-related gene family in the developing rat retina: persistent expression of SCLIP and stathmin in mature ganglion cell layer. Brain Res. 2000;861:399-407.
39. Odunuga OO, Longshaw VM, Blatch GL. Hop: more than an Hsp70/Hsp90 adaptor protein. Bioessays. 2004;26:1058-1068.
40. Voos W, Rottgers K. Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta. 2002;1592:51-62.
41. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA. 1992;89:10449-10453.
42. Golenhofen N, Ness W, Wawrousek EF, Drenckhahn D. Expression and induction of the stress protein alpha-B-crystallin in vascular endothelial cells. Histochem Cell Biol. 2002;117:203-209.
43. Parcellier A, Gurbuxani S, Schmitt E, Solary E, Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun. 2003;304:505-512.
44. Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis. 1999;5:28.
45. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
46. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227-7232.
47. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
48. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
49. Fitzgibbon J, Katsanis N, Wells D, Delhanty J, Vallins W, Hunt DM. Human guanylate kinase (GUK1): cDNA sequence, expression and chromosomal localisation. FEBS Lett. 1996;385:185-188.